Higher levels of HDAC2-AS2 were also detected in EVs from the plasma of HCC patients. Immune function analysis showed that ...

High-dimensional analysis identified SPON2 as the most predictive biomarker, with its expression pattern in NK cell subsets ...

Hepatocellular carcinoma (HCC) represents about 90% of all cases of liver cancer and has a poor prognosis, with a 5-year survival rate of about 18%. Previous findings had shown that RNA ...

induces innate immune signaling and death of hepatocellular carcinoma cells in vitro. Click here to read the article now. Michael Gale, Jr., from the University of Washington School of Medicine ...

Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, accounts for about 75–85% of all liver cancer cases. Immune checkpoint ...

General transcription factor IIIC subunit 2 (GTF3C2) is one of the polymerase III transcription-related factors. Previous studies have revealed that ...

The type depends on the type of cell that the cancer started in. Primary liver cancer is different to cancer that spreads to your liver from somewhere else in your body. This is called secondary liver ...

HCC is a type of liver cancer that originates in the main liver cells, known as hepatocytes. It is the most common form of primary liver cancer and typically occurs in individuals with a chronic liver ...

HCC is the third cause of death due to cancer ... which stimulate the immune system of patients to attack cancerous cells, has emerged with very promising results: a positive response in one ...

Although a diagnosis of HCC can be made with noninvasive radiologic criteria ... evaluating systemic therapies with novel mechanisms of action including adoptive cell therapy. This review aims to ...